|
NDUFS4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.698400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.896600E-01 |
| Normal-vs-Stage2 |
3.787400E-01 |
| Normal-vs-Stage3 |
1.771230E-01 |
| Normal-vs-Stage4 |
5.650200E-01 |
| Stage1-vs-Stage2 |
4.316400E-01 |
| Stage1-vs-Stage3 |
1.859600E-01 |
| Stage1-vs-Stage4 |
5.592800E-01 |
| Stage2-vs-Stage3 |
7.437200E-01 |
| Stage2-vs-Stage4 |
9.963600E-01 |
| Stage3-vs-Stage4 |
8.053000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.953200E-01 |
| Normal-vs-AfricanAmerican |
8.889000E-01 |
| Normal-vs-Asian |
6.894000E-01 |
| Caucasian-vs-AfricanAmerican |
5.355400E-01 |
| Caucasian-vs-Asian |
7.913200E-01 |
| AfricanAmerican-vs-Asian |
6.272000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.705400E-01 |
| Normal-vs-Female |
9.049800E-01 |
| Male-vs-Female |
4.911600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.735630E-01 |
| Normal-vs-Extreme_Weight |
6.735200E-01 |
| Normal-vs-Obese |
5.995200E-01 |
| Normal-vs-Extreme_Obese |
9.848600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.266370E-01 |
| Normal_Weight-vs-Obese |
5.187200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.210200E-01 |
| Extreme_Weight-vs-Obese |
4.214000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.884200E-01 |
| Obese-vs-Extreme_Obese |
8.097200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.489600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.959220E-01 |
| Normal-vs-Age(61-80Yrs) |
9.063000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.455000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.578000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.303400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.290600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.623800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.556640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.751800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.103000E-01 |
| Normal-VS-Type2 PRCC |
2.000600E-01 |
| Normal-VS-KIRP CIMP |
7.372000E-04 |
| Normal-VS-Unclassified PRCC |
1.731810E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.058300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.898990E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.625200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.371270E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.057800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.741100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.055600E-01 |
| Normal-vs-N1 |
2.141800E-01 |
| Normal-vs-N2 |
6.283200E-01 |
| N0-vs-N1 |
4.018000E-01 |
| N0-vs-N2 |
7.483000E-01 |
| N1-vs-N2 |
9.296200E-01 |
|
|
